awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28068643-DC043D40-5CC3-4C02-BF7B-161D5DC02E26
Q28068643-DC043D40-5CC3-4C02-BF7B-161D5DC02E26
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28068643-DC043D40-5CC3-4C02-BF7B-161D5DC02E26
Focus on Alectinib and Competitor Compounds for Second-Line Therapy in ALK-Rearranged NSCLC
P2860
Q28068643-DC043D40-5CC3-4C02-BF7B-161D5DC02E26
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28068643-DC043D40-5CC3-4C02-BF7B-161D5DC02E26
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f4c55b05dfcd5202fa5cb0b2f19c9777e64c8745
P2860
CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study.